189 related articles for article (PubMed ID: 21913888)
1. Whole organism based techniques and approaches in early stage oncology drug discovery-patents and trends.
Hampson RJ; Wyatt MD
Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):183-91. PubMed ID: 21913888
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic screening in cancer drug discovery - past, present and future.
Moffat JG; Rudolph J; Bailey D
Nat Rev Drug Discov; 2014 Aug; 13(8):588-602. PubMed ID: 25033736
[TBL] [Abstract][Full Text] [Related]
3. Zebrafish: Speeding Up the Cancer Drug Discovery Process.
Letrado P; de Miguel I; Lamberto I; Díez-Martínez R; Oyarzabal J
Cancer Res; 2018 Nov; 78(21):6048-6058. PubMed ID: 30327381
[TBL] [Abstract][Full Text] [Related]
4. Targeting Glycosylation: A New Road for Cancer Drug Discovery.
Costa AF; Campos D; Reis CA; Gomes C
Trends Cancer; 2020 Sep; 6(9):757-766. PubMed ID: 32381431
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
6. Simple animal models for amyotrophic lateral sclerosis drug discovery.
Patten SA; Parker JA; Wen XY; Drapeau P
Expert Opin Drug Discov; 2016 Aug; 11(8):797-804. PubMed ID: 27249162
[TBL] [Abstract][Full Text] [Related]
7. New sources of drugs for hematologic malignancies.
Sukhai MA; Spagnuolo PA; Weir S; Kasper J; Patton L; Schimmer AD
Blood; 2011 Jun; 117(25):6747-55. PubMed ID: 21511957
[TBL] [Abstract][Full Text] [Related]
8. The Role of Alternative Toxicological Trials in Drug Discovery Programs. The Case of
Göethel G; Augsten LV; das Neves GM; Gonçalves IL; de Souza JPS; Garcia SC; Eifler-Lima VL
Curr Med Chem; 2022; 29(32):5270-5288. PubMed ID: 35352642
[TBL] [Abstract][Full Text] [Related]
9. Using zebrafish models of leukemia to streamline drug screening and discovery.
Deveau AP; Bentley VL; Berman JN
Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
[TBL] [Abstract][Full Text] [Related]
10. Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.
Sandercock AM; Rust S; Guillard S; Sachsenmeier KF; Holoweckyj N; Hay C; Flynn M; Huang Q; Yan K; Herpers B; Price LS; Soden J; Freeth J; Jermutus L; Hollingsworth R; Minter R
Mol Cancer; 2015 Jul; 14():147. PubMed ID: 26227951
[TBL] [Abstract][Full Text] [Related]
11. Herbal drug patenting in India: IP potential.
Sahoo N; Manchikanti P; Dey SH
J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
[TBL] [Abstract][Full Text] [Related]
12. C. elegans in high-throughput drug discovery.
O'Reilly LP; Luke CJ; Perlmutter DH; Silverman GA; Pak SC
Adv Drug Deliv Rev; 2014 Apr; 69-70():247-53. PubMed ID: 24333896
[TBL] [Abstract][Full Text] [Related]
13. Drug Discovery in Fish, Flies, and Worms.
Strange K
ILAR J; 2016 Dec; 57(2):133-143. PubMed ID: 28053067
[TBL] [Abstract][Full Text] [Related]
14. Developments in preclinical cancer imaging: innovating the discovery of therapeutics.
Conway JR; Carragher NO; Timpson P
Nat Rev Cancer; 2014 May; 14(5):314-28. PubMed ID: 24739578
[TBL] [Abstract][Full Text] [Related]
15. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
Eglen RM; Randle DH
Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs.
Coussens NP; Braisted JC; Peryea T; Sittampalam GS; Simeonov A; Hall MD
Pharmacol Rev; 2017 Oct; 69(4):479-496. PubMed ID: 28931623
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in the use of zebrafish for novel cardiac drug discovery.
Keßler M; Rottbauer W; Just S
Expert Opin Drug Discov; 2015; 10(11):1231-41. PubMed ID: 26294375
[TBL] [Abstract][Full Text] [Related]
18. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
Delvecchio C; Tiefenbach J; Krause HM
Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
[TBL] [Abstract][Full Text] [Related]
19. High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics.
Ben-Yakar A
Assay Drug Dev Technol; 2019 Jan; 17(1):8-13. PubMed ID: 30657702
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 90 inhibitors as therapeutic agents.
Gomez-Monterrey I; Sala M; Musella S; Campiglia P
Recent Pat Anticancer Drug Discov; 2012 Sep; 7(3):313-36. PubMed ID: 22338602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
